Changing perspectives in pre-existing diabetes and obesity in pregnancy: Maternal and infant short- and long-term outcomes

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 21, Issue 4, 2014, Pages 257-263

  Barbour, Linda A ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

fetal programming; gestational weight gain; obesity; type 1 diabetes mellitus; type 2 diabetes mellitus

Indexed keywords

GLUCOSE; INSULIN; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL;

BARIATRIC SURGERY; BLOOD GLUCOSE MONITORING; CESAREAN SECTION; CHILDHOOD OBESITY; COMPARATIVE STUDY; CONTINUOUS GLUCOSE MONITORING; DIET RESTRICTION; GLUCOSE BLOOD LEVEL; HUMAN; INFANT DISEASE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TREATMENT; LONG TERM CARE; MACROSOMIA; MALNUTRITION; MATERNAL DIABETES MELLITUS; MATERNAL OBESITY; META ANALYSIS (TOPIC); NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL ACTIVITY; PRACTICE GUIDELINE; PREECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; REVIEW; SHORT COURSE THERAPY; UTERUS; WEIGHT GAIN; ADULT; BLOOD; COMPLICATION; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HYPERGLYCEMIA; MOTHER; NEWBORN; OBESITY; PATHOPHYSIOLOGY; PREGNANCY COMPLICATION; PREGNANCY IN DIABETICS; PRENATAL EXPOSURE; PREVALENCE;

ADULT; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INFANT, NEWBORN; INSULIN; INSULIN RESISTANCE; MOTHERS; OBESITY; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY IN DIABETICS; PREGNANCY OUTCOME; PRENATAL EXPOSURE DELAYED EFFECTS; PREVALENCE;

EID: 84903815256     PISSN: 1752296X     EISSN: 17522978     Source Type: Journal    
DOI: 10.1097/MED.0000000000000079     Document Type: Review

References (73)

1. Flegal KM, Carroll MD, Kit BK, OgDen CL. Prevalence of obesity and trends in the distribution of body mass inDex among US adults, 1999-2010. JAMA 2012; 307:491-497.
2. Heerwagen MJ, Miller MR, Barbour LA, Friedman JE. Maternal obesity and fetal metabolic programming: a fertile epigenetic soil. Am J Physiol Regul Integr Comp Physiol 2010; 299:R711-R722.
3. Nolan CJ, Damm P, Prentki M. Type 2 diabetes across generations: from pathophysiology to prevention and management. Lancet 2011; 378:169-181.
4. Nolan CJ. Normal long-term health for infants of diabetic mothers: can we achieve it? J Clin Endocrinol Metab 2013; 98:3592-3594.
5. Patti M-E. Intergeneration programming of metabolic disease; eviDence from human populations and experimental animal moDels. Cell Moll Life Sci 2013; 70:1597-1616.
6. Lillycrop KA, Burdge GC. Epigenetic mechanisms linking early nutrition to long term health. Best Pract Res Clin Endocrinol Metab 2012; 26:667-676.
7. Pinney SE, Simmons RA. Metabolic programming, epigenetics, and gestational diabetes. Curr Diab Repor 2012; 12:67-74.
8. Mitanchez D, Burguet A, Simeoni U. Infants born t o mothers with gestational diabetes mellitus; mild neonatal effects, a long-term threat to global health. J Pediatr 2014; 164:445-450.
9. Chen JR, Zhang J, Lazarenko OP, et al. Inhibition of fet al bone Development through epigenetic down-regulation of HoxA10 in obese rats fed high-fat diet. FASEB J 2012; 26:1131-1141.
10. Symonds ME, Pope M, Sharkey D, et al. Adipose tissue and fetal programming. Diabetologia 2012; 55:1597-1606.
11. SulliVan EL, Grayson B, Takahashi D, et al. Chronic consumption of a high fat diet during pregnancy causes perturbations in the serotonergic system and increased anxiety-like behavior in nonhuman primate offspring. J Neuroscience 2010; 30:3826-3830.
12. M cCurdy CE, Bishop JM, Williams SM, et al. Maternal high-fat diet triggers lipotoxicity in the fetal livers of nonhuman primates. J Clin Invest 2009; 119:323-335.
13. Suter MA, Chen A, Bur dine MS, et al. A maternal high-fat diet modulates fetal SIRT1 histone and protein Deacetylase activity in nonhuman primates. FASEB J 2012; 26:5106-5114.
14. Sassone-Corsi P. When metabolism and epigenetics converge. Science 2013; 339:148-149.
15. Vrachnis N, Antonakopoulos N, Iliodromiti Z, et al. Impact of maternal diabetes on epigenetic modifications leading to diseases in the offsprin g. Exp Diabetes Res 2012; 2012:1-6.
16. Malcolm J, Through the looking glass: gestational diabetes as a predictor of maternal and offspring long-term health,Diabetes Metab Res Rev,2012, 28,307-311.
17. Portha B, Chavey A, Movassat J. Early-life origins of type 2 diabetes: fetal programming of the beta cell mass. Exp Diabetes Res 2011; 2011:1-16.
18. Keely E, Barbour LA. Management of diabetes in pregnancy. Endotext 2013; 1-46; Chapter 20.
19. Radaelli T, Lepercq J, Varastehpour A, et al. Differential regulation of genes for fetoplacental lipid pathways in pregnancy with gestational and type 1 diabetes mellitus. Am J Obstet Gynecol 2009; 201:209.e1-209.e10.
20. Aye IL, Powell TL, Jansson T. Adiponectin-the missing link between maternal adiposity, placental transport, and fetal growth? Placenta 2013; 34:S40-S45.
21. Dabelea DT. Crume, maternal environment and the transgenerational cycle of obesity and diabetes. Diabetes 2011; 60:1849- 1855.
22. Kelstrup L, Damm P, Mathiesen ER, et al. Insulin resistance and impaired pancreatic B-cell function in adult offspring of women with diabetes in pregnancy. J Clin Endocrinol Metab 2013; 98:3793-3801 .
23. Kral JG, Biron S, Simard S, et al. Large maternal weight loss from obesity surgery prevents transmission of obesity to children who were followed for 2 to 18 years. Pediatrics 2006; 118:e16 44-e1649. (Pubitemid 46397537)
24. Brumbaugh DE, Tearse P, Cree-Green M, et al. Intrahepatic fat is increased in the neonatal offspring of obese women with gestational diabetes. J Pediatr 2012; 162:930-936.
25. Watkins ML, Rasmussen SA, Honein MA, et al. Maternal obesity and risk for birth Defects. Pediatrics 2003; 111:1152-1158. (Pubitemid 36539220)
26. Vrebosch L, Bel S, Vansant G, et al. Maternal and neonatal outcome after laparoscopic adjustable gastric banding: a systematic review. Obes Surg 2012; 22:1568-1579.
27. Harmon KA, Gerard L, Jensen DR, et al. Continuous glucose profiles in obese and normal-weight pregnant women on a controlled diet: metabolic Determinants of fetal growth. Diabetes Care 2011; 34:2198-2204.
28. Schaefer-Graf UM, Graf K, Kulbacka I, Kjos SL, et al. Maternal lipids as strong Determinants of fetal environment and growth in pregnancies with gestational diabetes mellitus. Diabetes Care 2008; 31:1858-1863.
29. Barbour L, HernanDez T, VanPe lt R, et al. Change in fasting triglyceriDes from early to late gestation is highly predictive of neonatal adiposity. ADA Diabetes 2009; 58 (Suppl 1):A84.
30. Whyte K, Kelly H, O'Dwyer V, et a l. Offspring birth weight and maternal fasting lipids in women screened for gestational diabetes mellitus (GDM). Eur J Obstet Gynecol Reprod Biol 2013; 170:67-70.
31. Whitaker RC. Predicting preschoole r obesity at birth: the role of maternal obesity in early pregnancy. Pediatrics 2004; 114:29-36.
32. Black MH, Sacks DA, Xiang A, et al. The relative contribution of prepregnancy overweight and o besity, gestational weight gain, and IADPSG-Defined gestational diabetes mellitus to fetal overgrowth. Diabetes Care 2013; 36:56-62.
33. Catalano PM, Farrell K, Thomas A, et al. Perinatal risk factors for childhood obesity and metabolic dysregulation. Am J Clin Nutr 2009; 90:1303-1313.
34. Catalano PM, McIntyre DH, Cruickshank JK; the HAPO Cooperative Research Group. The Hyperglycemia and Adverse Pregnancy Outcome Study: associations of GDM and obesity with pregnancy outcomes. Diabetes Care 2012; 35:780-786.
35. Institute of Medicine (IOM). US, Subcommittee on nutritional status and weight gain during pregnancy. Weight gain during pregnancy: reexamining the guiDelines. Washington, DC: National AcaDemy Press; 2009.
36. Rasmussen KM, Yaktine AL, eds.; Institute of Medicine and National Research Council Committee to Reexamine IOM Pregnancy Weight GuiDelines. Weight gain during pregnancy: reexamining the guiDelines. Washington, DC, National AcaDemies Press, 2009, 1-250.
37. Barbour LA, Weight gain in pregnancy, is more truly less for mother and child? J Obstet Med, June,2012,5,58-64.
38. Blomberg M. Maternal and neonatal outcomes among obese women with weight gain below the new Institute of Medicine recommendations. Obstet Gynecol 2011; 117:1065-1070.
39. Oken E, Tav eras EM, Kleinman KP, et al. Gestational weight gain and child adiposity at age 3 years. Am J Obstet Gynecol 2007; 196:322-328.
40. Oken E. Maternal and child obesity: the causal link. Obstet Gynecol Clin North Am 2009; 36:361-377.
41. Hinkle SN, Sharma AJ, Dietz PM. Gestational weight gain in obese mothers and associations with fetal growth. Am J Clin Nutr 2010; 92:644-651.
42. Margerison Zilko CE, Rehkopf D, Abrams B. Association of maternal gestational weight gain with short-and long-term maternal and child health outcomes. Am J Obstet Gynecol 2010; 202:574-57 8.
43. Bodnar LM, Siega-Riz AM, Simhan HN, et al. Severe obesity, gestational weight gain, and adverse birth outcomes. Am J Clin Nutr 2010; 91:1642-1648.
44. Artal R, Lockwood CJ, Brown HL. Weight gain recommendations in pregnancy and the obesity epiDemic. Obstet Gynecol 2010; 115:152-155.
45. Herring SJ, Rose MZ, Skouteris H, Oken E. Optimizing weight gain in pregnancy to prevent obesity in women and children. Diabetes Obes Metab 2012; 14:195-203.
46. Siega-Riz AM, Viswanathan M, Moos A, et al. A systematic review of outcomes of maternal weight gain according to the Institute of Medicine recommendations: birthweight, fetal growth, and postpartum weight retention. Am JObstet Gynecol 2009; 201:339.e1-339.e14.
47. EunPark J, Park S, Daily JW, Kim SH. Low gestational weight gain improves infant and maternal pregnancy outcomes in overweight and obese Korean women with gestational diabetes. Gynecol Endocrinol 2011; 27:775-781.
48. Katon J, Reiber G, Williams MA, et al. Weight loss after diagnosis with gestational diabetes and birth weight among overweight and obese women. Matern Child Health J 2013; 17:374-383.
49. Asbjornsdottir B, Rasmussen SS, Kelstrup L, et al. Impact of restricted maternal weight gain on fetal growth and perinatal morbidity in obese women with type 2 diabetes. Diabetes Care 2013; 36:1102-1106.
50. Thangaratinam S, Rogozinska E, Jolly Ket al. Effects of interventions in pregnancy on maternal weight and obstetric outcomes: a meta-analysis of randomized eviDence. BMJ 2012; 344:1-15.
51. Skouteris H, Clark-Hartle y L, McCabe M, et al. Preventing excessive gestational weight gain: a systematic review of interventions. Obesity reviews 2012; 11:757-768.
52. Ruchat SM, Mottola MF. The important role of physical activity in the prevention and management of gestational diabetes mellitus. Diab Metab Res Rev 2013; 29:334-346.
53. HernanDez T L, Friedman JE, Van Pelt RE, Barbour LA. Patterns of glycemia in normal pregnancy: should the current therapeutic targets be challenged? Diabetes Care 2011; 34:1660-1668.
54. Siegmund T, Rad NT, Ritterath C, et al. Longitudinal changes in the continuous glucose profile measured by the CGMS in healthy pregnant women and Determination of cut-off values. Eur J Obstet Gynecol Reprod Biol 2008; 139:46-52.
55. Prutsky GJ, Domecq JP, Wang Z, et al. Glucose targets in pregnant women with diabetes: a systematic review and meta-analysis. J Clin Endocrinol Metab 2013; 98:4319-4324.
56. Groen B, Links TP, Van Den Berg PP, et al. Similar adverse pregnancy outcome in native and nonnative Dutch women with pregestational type 2 diabetes; a multicenter retrospective study. ISRN Obstet Gynecol 2013; 361435:1-7.
57. Clausen TD, Mathiesen E, Ekbom P, et al. Poor pregnancy outcome in women with type 2 diabetes. Diabetes Care 2005; 28:323-328. (Pubitemid 40170934)
58. Cundy T,Gamble G,Neale L,et al, Differing causes of pregnancy loss in type 1 and type 2 diabetes,Diabetes Care, 2007,30,2603-2607. (Pubitemid 47547804)
59. Mathiesen JM, Secher AL, Ringholm L, et al. Changes in basal rates and bolus ca lculator settings in insulin pumps during pregnancy in women with type 1 diabetes. J Matern Fetal Neonatal Med 2013; 27:724-728.
60. Ringholm L, Secher AL, PeDersen-Bjergaard U, et al. The incid ence of severe hypoglycaemia in pregnant women with type 1 diabetes mellitus can be reduced with unchanged HbA1c levels and pregnancy outcomes in a routine care setting. Diabetes Res Clin Pract 2013; 101:123-130.
61. . Lambert K, Holt RIG. The use of insulin analogues in pregnancy. Diabetes Obes Metab 2013; 15:888-900.
62. Lepercq J, JLin J, Hall GC, et al. Meta-analysis of maternal and neonatal outcomes associated with the use of insulin glargine versus NPH insulin during pregnancy. Obstet Gynecol Int 2012; 2012:649070.
63. Mathiesen ER, Hod M, IVanisevic M, et al. Maternal efficacy a nd safety outcomes in a randomized, controlled trial comparing insulin Determir with NPH insulin in 310 pregnant women with type 1 diabetes. Diabetes Care 2012; 35:2012-2017.
64. Castorino K, Paband R, Z isser H, JoVanovic? L. Insulin pumps in pregnancy: using technology to achieve normoglycemia in women with diabetes. Curr Diab Rep 2012; 12:53-59.
65. Hickman MA, McBriDe R, Boggess KA, Straus R . Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. Amer J Perinatol 2013; 30:483-490.
66. Murphy HR, Rayman G, Lewis K, et al. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomized clinical trial. BMJ 2008; 337:1-l8.
67. Secher AL, Ringholm L, AnDersen HU, et al. The effect of real-time continuous glucose monitoring in pregnant women with diabetes. A randomized controlled trial. Diabetes Care 2013; 36:1877 -1883.
68. Herna nDez TL, Barbour LA. A standard approach to continuous glucose monitor data in pregnancy for the study of fetal growth and infant outcomes. Diab Technol Therap 2013; 15:1-8.
69. Murphy HR, Elleri D, Allen JM, et al. Closed-loop insulin Delivery during pregnancy complicated by type 1 diabetes. Diabetes Care 2011; 34:406-411.
70. Bell R, Glinianaia P, Tennant PWG, et al. Pericon ception hyperglycaemia and nephropathy are associated with risk of congenital anomaly in women with preexisting diabetes: a population-based cohort. Diabetologia 2012; 55:936-947.
71. Tennant PWG, Glinianaia SV, Bilous RW, et al. Preexisting diabetes, maternal glycated haemoglobin, and the risks of fetal and infant Death: a populationbased study. Diabetologia 2014; 57:285-294.
72. Keely E. Preconc eption care for women with type 1 and type 2 diabetes-the same but different. Can J Diabetes 2012; 36:83-86.
73. Finkelstein SA, Keely E, Feig DS, et al. Breastfeeding in women with diabetes: lo wer rates Despite greater rewards. A population-based study. Diabet Med 2013; 30:1094-1101.